ClinicalTrials.gg
RecruitingNCT06073704Updated May 4, 2026

Effects of Adjunct Antimicrobial Photodynamic Therapy in Periodontal Treatment of Patients With Obesity

An interventional study of antimicrobial photodynamic therapy (aPDT) and Control in Periodontitis and Obesity, sponsored by University of Sao Paulo. Recruiting at 1 site in Brazil. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Oct 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Periodontitis by University of Sao Paulo — 3 open to participants now, 4 under way, none of them phase 3. Periodontitis · University of Sao Paulo.

Planned enrollment
11th of 12
24 · median 46
Started
2023
with 2 others
No phase
6 of 13
3 open now
Registered
8th of 13
by date

Among the 13 studies in Periodontitis by University of Sao Paulo, this one is the 11th largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2023, is one of 6 with no phase, and was the 8th registered.

Periodontitis

1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.

Browse Periodontitis studies →

Open to participants now

3 of the 13 studies in Periodontitis by University of Sao Paulo are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 163 Periodontitis studies recruiting now, 80 (49%) set no upper age limit and 62 (38%) stop at 75 or younger; 12 take children under 18; 80 take healthy volunteers.

This study: 18 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Periodontitis by University of Sao Paulo, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare the effects of adjuvant antimicrobial photodynamic therapy (aPDT) as an adjuvant of scaling and root planing with scaling and root planing alone for periodontal treatment in patients with periodontal disease and obesity. The main question it aims to answer are: Does adjuvant aPDT improves periodontal health? Are there differences in the proteomic profile of gingival fluid after both treatments? Participants will receive scaling and root planing complemented or not by aPDT. Results will be collected after 1, 3, and 6 months. Researchers will compare adjuvant aPDT treatment to regular treatment to see if it promotes reduction in inflammation and improvement in periodontal health.

03

Conditions studied

  • Periodontitis
  • Obesity

Keywords

  • periodontitis
  • obesity
04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Obesity (grade II and III classified according to )
  • Periodontitis stage II to IV
  • Presence of at least 20 teeth excluding 3rd molars.

Exclusion criteria

Exclusion Criteria:

  • Smokers
  • Alcohol or drugs consumption
  • Kidney disorders
  • Pregnancy or lactation
  • Use of antibiotics at the last 30 days
  • Use of drugs that alter periodontal structures as phenytoin or ciclosporin
  • Periodontal treatment at the last 6 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Antimicrobial Photodynamic therapy adjunct to scaling and root planing

    Treatment of scaling and root planing followed by antimicrobial photodynamic therapy with methylene blue (100 micrograms/ml) and red laser

    Procedure: antimicrobial photodynamic therapy (aPDT)

  • Active comparator
    Control

    Treatment of scaling and root planing.

    Procedure: Control

Interventions

  • Procedureantimicrobial photodynamic therapy (aPDT)

    Scaling and root planing followed by antimicrobial photodynamic therapy

    Also known as: Photodynamic therapy, Photochemotherapy

  • ProcedureControl

    Treatment of scaling and root planing

    Also known as: scaling and root planing

06

What researchers measure

Primary outcomes

  1. Probing depth

    Changes in probing depth measured from the gingival margin to the bottom of periodontal sulcus or periodontal pocket by a periodontal probe in millimeters.

    Time frame: Baseline, 1, 3 and 6 months

  2. Clinical attachment level

    Changes in clinical attachment level measured from the cemento-enamel junction to the bottom of periodontal sulcus or periodontal pocket by a periodontal probe in millimeters.

    Time frame: Baseline, 1, 3 and 6 months

Secondary outcomes

  1. Changes on bleeding on probing

    Changes in percentage of sites with bleeding after probing. Six sites per tooth are examined and presence/absence of bleeding is recorded.

    Time frame: Baseline, 1,3,and 6 months

  2. Differences in proteomics

    Changes in inflammatory proteins after treatment by proteomics assay. Presence or absence of proteins in gingival fluid are compared before and after treatment.

    Time frame: baseline, 3 and 6 months

07

Study locations

1 of 1 sites recruiting
  • Bauru School of Dentistry
    Bauru, São Paulo 17012-901, Brazil
    Recruiting
    • Carla Damante, PhD · Contactcdamante@usp.br · +55 14 32266064
    • Andreia Pavani, PhD · Contacta-deia@hotmail.com · +55 14 32358366
    • Carla Damante, PhD · Principal investigator
    • Andreia Pavani, PhD · Sub investigator
08

References and documents

Publications

  • Vohra F, Akram Z, Bukhari IA, Sheikh SA, Javed F. Short-term effects of adjunctive antimicrobial photodynamic therapy in obese patients with chronic periodontitis: A randomized controlled clinical trial. Photodiagnosis Photodyn Ther. 2018 Mar;21:10-15. doi: 10.1016/j.pdpdt.2017.10.022. Epub 2017 Oct 27. PubMed 29111391 ↗
  • da Silva-Junior PGB, Abreu LG, Costa FO, Cota LOM, Esteves-Lima RP. The effect of antimicrobial photodynamic therapy adjunct to non-surgical periodontal therapy on the treatment of periodontitis in individuals with type 2 diabetes mellitus: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2023 Jun;42:103573. doi: 10.1016/j.pdpdt.2023.103573. Epub 2023 Apr 14. PubMed 37062511 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Jul 2026, 33 months after the start.

Of 484 non-industry interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's planned 33 months is above that.

Counting every sponsor, half of 498 studies reached it within 15 months; a quarter within 8 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2023
First posted
Oct 10, 2023
StartActual
Oct 9, 2023
Primary completionEst.
Jul 30, 2026
CompletionEst.
Dec 30, 2026
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06073704
Responsible party
Carla Andreotti Damante (Associate professor, University of Sao Paulo) — Principal investigator
First posted
Oct 10, 2023
Start date
Oct 9, 2023
Primary completion
Jul 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
May 4, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion